Statistics for Mirum Pharmaceuticals (id:6476 MIRM)

Valuation metrics

Market cap

2.22B

Enterprise value

2.14B

Trailing P/E (ttm)

-11.18

Forward P/E

-53.17

PEG ratio

-53.17

Price/Sales (ttm)

7.23

Price/Book (mrq)

9.56

Enterprise Value/Revenue

6.98

Enterprise Value/EBITDA

-29.38

Overview

Shares outstanding

47.71M

Float

36.23M

Shares short

6.85M

% Held by insiders

0.02%

% Held by institutions

1.18%

Average volume (10 days)

521.75K

Average volume (90 days)

Price summary

52-Week low

23.14

52-Week high

48.89

52-Week change

27.68%

Beta

1.16

50-Day moving average

39.96

200-Day moving average

33.07

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-32.51%

Operating margin

-14.04%

Operational effectiveness

Return on assets

-9.10%

Return on equity

-39.84%

Income statement

Revenue (ttm)

6.51

Revenue per share (ttm)

6.51

Quarterly revenue growth (yoy)

Gross profit (ttm)

139.34M

EBITDA

-72,902,000.00

Net income to common (ttm)

-99,811,000.00

Diluted EPS (ttm)

-2.31

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

284.44M

Total cash per share (mrq)

5.92

Total debt (mrq)

317.65M

Total Debt/Equity (mrq)

136.90

Current ratio (mrq)

334.00%

Book value per share (mrq)

4.84

Cash flow

Cash flow statement

-1,225,000.00

Levered free cash flow (LFCF)

-3,104,000.00